Stay updated on Clinical Trial: INO-3112 & Durvalumab for HPV Cancers

Sign up to get notified when there's something new on the Clinical Trial: INO-3112 & Durvalumab for HPV Cancers page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial: INO-3112 & Durvalumab for HPV Cancers page

  1. Check
    3 days ago
    Change Detected
    Summary
    Updates the platform’s displayed revision number from v3.5.2 to v3.5.3 for the study details view.
    Difference
    0.0%
    Check dated 2026-04-24T05:56:37.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:12:43.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Difference
    0.0%
    Check dated 2026-03-19T00:15:20.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 of the page template. The update is a back-end/template change and does not modify study data or visible content.
    Difference
    0.0%
    Check dated 2026-03-11T17:58:26.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The updates look like a layout/content reorganization of the study page. No trial data, eligibility criteria, or outcomes appear to have changed.
    Difference
    0.0%
    Check dated 2026-03-04T13:52:53.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Added: Revision: v3.4.2; the previous Notice about government funding and Revision: v3.4.1 were removed, indicating an administrative page revision update without changes to the study content.
    Difference
    0.4%
    Check dated 2026-02-11T09:18:10.000Z thumbnail image

Stay in the know with updates to Clinical Trial: INO-3112 & Durvalumab for HPV Cancers

Enter your email address, and we'll notify you when there's something new on the Clinical Trial: INO-3112 & Durvalumab for HPV Cancers page.